Your browser doesn't support javascript.
loading
Cone-Beam CT Images as an Indicator of QACT During Adaptive Proton Therapy of Extremity Sarcomas.
Biswal, Nrusingh C; Zhang, Baoshe; Nichols, Elizabeth; Witek, Matthew E; Regine, William F; Yi, ByongYong.
Afiliação
  • Biswal NC; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.
  • Zhang B; Maryland Proton Treatment Center, Baltimore, MD 21201.
  • Nichols E; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.
  • Witek ME; Maryland Proton Treatment Center, Baltimore, MD 21201.
  • Regine WF; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.
  • Yi B; Maryland Proton Treatment Center, Baltimore, MD 21201.
Int J Part Ther ; 12: 100017, 2024 Jun.
Article em En | MEDLINE | ID: mdl-39022119
ABSTRACT

Purpose:

Periodic quality assurance CTs (QACTs) are routine in proton beam therapy. In this study, we tested whether the necessity for a QACT could be determined by evaluating the change in beam path length (BPL) on daily cone-beam CT (CBCT). Patients and

Methods:

In this Institutional Review Board-approved study, we retrospectively analyzed 959 CBCT images from 78 patients with sarcomas treated with proton pencil-beam scanning. Plans on 17 QACTs out of a total of 243 were clinically determined to be replanned for various reasons. Daily CBCTs were retrospectively analyzed by automatic ray-tracing of each beam from the isocenter to the skin surface along the central axis. A script was developed for this purpose. Patterns of change in BPL on CBCT images were compared to those from adaptive planning using weekly QACTs.

Results:

Sixteen of the 17 adaptive replans showed BPL changes ≥4 mm for at least 1 of the beams on 3 consecutive CBCT sessions. Similarly, 43 of 63 nonadaptively planned patients had BPL changes <4 mm for all of the beams. A new QACT criterium of a BPL change of any beam ≥4 mm on 3 consecutive CBCT sessions resulted in a sensitivity of 94.1% and a specificity of 68.3%. Had the BPL change been used as the QACT predictor, a total of 37 QACTs would have been performed rather than 243 QACTs in clinical practice.

Conclusion:

The use of BPL changes on CBCT images represented a significant reduction (85%) in total QACT burden while maintaining treatment quality and accuracy. QACT can be performed only when it is needed, but not in a periodic manner. The benefits of reducing QACT frequency include reducing imaging dose and optimizing patient time and staff resources.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Int J Part Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Int J Part Ther Ano de publicação: 2024 Tipo de documento: Article